About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Biomedical Research Group in Gynaecology is a multidisciplinary team made up of clinical specialists in gynaecology and pathology and basic and translational researchers. Our research is clearly translational. Although we take into account the obvious importance of understanding the mechanism at the cellular and molecular level and try to incorporate it into our research, our research is always focused on having a direct applicability to patients and their clinical benefit. On our way to transferring scientific results to clinical practice, we promote innovation and entrepreneurship.
Our group comprises four main research groups, which are closely connected: The clinical research group devoted mainly to clinical projects in all gynaecological cancers; and three translational research groups dedicated to ovarian cancer; endometrial cancer and endometriosis; diseases of the lower female genital tract.
IP: Antonio Gil Moreno Collaborators: Carina Masferrer Ferragutcasas, Marta Rebull Santamaria, Irene De la Calle Fuentes, Beatriz Villafranca Magdalena, Melek Denizli Funding agency: Asociación Española Contra el Cáncer Funding: 199250 Reference: GCTRA18014MATI Duration: 18/02/2019 - 31/10/2024
IP: Meritxell Genesca Ferrer Collaborators: Vicente Descalzo Jorro, Josep Castellví Vives, Laura Mañalich Barrachina Funding agency: Instituto de Salud Carlos III Funding: 171820 Reference: PI20/00160 Duration: 01/01/2021 - 30/06/2025
IP: Matilde Lleonart Pajarin Collaborators: Yoelsis Garcia Mayea, Jordi Temprana Salvador, Angel García Jiménez, Josep Castellví Vives, Laia Josa Culleré, Marina Bataller Fernández Funding agency: Instituto de Salud Carlos III Funding: 183920 Reference: PI20/00556 Duration: 01/01/2021 - 30/06/2025
IP: Eva Colas Ortega Collaborators: Carina Masferrer Ferragutcasas, Fco Javier De la Torre Fdez de Vega, Silvia Cabrera Diaz, Irene De la Calle Fuentes, Beatriz Villafranca Magdalena Funding agency: Instituto de Salud Carlos III Funding: 135520 Reference: PI20/00644 Duration: 01/01/2021 - 31/12/2024
PMID: 37929250 Journal: Year: 2023 Reference: Ultrasound. 2023 Nov;31(4):292-299. doi: 10.1177/1742271X231157618. Epub 2023 Mar 17. Impact factor: Publication type: Paper in international publication Authors: Albert, Eliseo; Amat, Paula; Balaguer, Aitana; Barba, Pere; Beas, Francisco; Benzaquen, Ana; Bradbury, Melissa; Campos, Diana; Capell-Morell, Montserrat; Carpio, Cecilia et al. DOI: 10.1177/1742271X231157618
PMID: 37936221 Journal: BMC HEALTH SERVICES RESEARCH Year: 2023 Reference: BMC Health Serv Res. 2023 Nov 7;23(1):1220. doi: 10.1186/s12913-023-10274-4. Impact factor: Publication type: Paper in international publication Authors: Ariza-Sole, Albert; Bradbury, Melissa; Capell-Morell, Montserrat; Cubo-Abert, Montserrat; Diaz-Feijoo, Berta; Ferrer, Ricard; Garcia-Jimenez, Angel; Gil-Moreno, Antonio; Gomez-Cabeza, Juan-Jose; Gomez-Lopez, Rocio et al. DOI: 10.1186/s12913-023-10274-4
PMID: 38033506 Journal: EClinicalMedicine Year: 2023 Reference: EClinicalMedicine. 2023 Nov 15;65:102307. doi: 10.1016/j.eclinm.2023.102307. eCollection 2023 Nov. Impact factor: Publication type: Paper in international publication Authors: Abdelrahman Soliman, Dina Sameh; Al-Shemari, Salem; Alcoceba, Miguel; Alobid, Isam; Angelopoulou, Maria; Antic, Darko; Aurran-Schleinitz, Therese; Bacchiarri, Francesca; Bellido, Mar; Biderman, Bella et al. DOI: 10.1016/j.eclinm.2023.102307
PMID: 38062117 Journal: npj Precision Oncology Year: 2023 Reference: NPJ Precis Oncol. 2023 Dec 8;7(1):127. doi: 10.1038/s41698-023-00478-6. Impact factor: Publication type: Paper in international publication Authors: Bonazzi, Vanessa; Chetty, Naven; Colas, Eva; Frentzas, Sophia; Gil-Moreno, Antonio; Lourie, Rohan; Moiola, Cristian P; Perrin, Lewis; Pollock, Pamela M; Rogers, Rebecca et al. DOI: 10.1038/s41698-023-00478-6
PMID: 35303394 Journal: BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY Year: 2022 Reference: BJOG. 2022 Mar 18. doi: 10.1111/1471-0528.17151. Impact factor: 6.531 Publication type: Paper in international publication Authors: Carreras, Elena, Armengol, Mireia, Bonacina, Erika, Mendoza, Manel, Farras, Alba, Garcia-Manau, Pablo, Serrano, Berta, Hurtado, Ivan, Ferrer-Oliveras, Raquel, Illan, Lidia et al. DOI: 10.1111/1471-0528.17151
PMID: 35292711 Journal: Scientific Reports Year: 2022 Reference: Sci Rep. 2022 Mar 15;12(1):4445. doi: 10.1038/s41598-022-08461-0. Impact factor: 4.38 Publication type: Paper in international publication Authors: Gil-Moreno, Antonio, Sabido, Eduard, Santamaria, Anna, Perez-Benavente, Assumpcio, Sanchez-Iglesias, Jose Luis, Castellvi, Josep, Bradbury, Melissa, Borras, Eva, Mendez, Olga et al. DOI: 10.1038/s41598-022-08461-0
PMID: 34217852 Journal: Journal of Minimally Invasive Gynecology Year: 2022 Reference: J Minim Invasive Gynecol. 2022 Jan;29(1):103-113. doi: 10.1016/j.jmig.2021.06.027. Epub 2021 Jul 1. Impact factor: 4.137 Publication type: Paper in international publication Authors: Diaz-Feijoo, Berta, Acosta, Ursula, Torne, Aureli, Gil-Ibanez, Blanca, Hernandez, Alicia, Domingo, Santiago, Gil-Moreno, Antonio et al. DOI: 10.1016/j.jmig.2021.06.027
From 6th to 7th March, more than 60 European researchers have shared the advances in translational research in endometrial cancer
On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.
A team from Vall d'Hebron Research Institute (VHIR) and the Autonomous University of Barcelona (UAB) highlights the ERK5 protein as a key factor in the resistance to cancer drugs.
